EFFECTOR Therapeutics Analysis
| EFTRWDelisted Stock | USD 0 0.00 0.00% |
EFFECTOR Therapeutics is overvalued with Real Value of 9.5E-4 and Hype Value of 0.00125. The main objective of EFFECTOR Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what EFFECTOR Therapeutics is worth, separate from its market price. There are two main types of EFFECTOR Therapeutics' stock analysis: fundamental analysis and technical analysis.
The EFFECTOR Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
EFFECTOR |
EFFECTOR Pink Sheet Analysis Notes
The company recorded a loss per share of 0.91. EFFECTOR Therapeutics had not issued any dividends in recent years. The quote for EFFECTOR Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about EFFECTOR Therapeutics call Stephen Worland at 858 925 8215 or check out https://effector.com.EFFECTOR Therapeutics Investment Alerts
| EFFECTOR Therapeutics is not yet fully synchronised with the market data | |
| EFFECTOR Therapeutics has some characteristics of a very speculative penny stock | |
| EFFECTOR Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EFFECTOR Therapeutics generates negative cash flow from operations |
EFFECTOR Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EFFECTOR Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on EFFECTOR Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EFFECTOR Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Presidio Management Group X Llc over six months ago Disposition of 799 shares by Presidio Management Group X Llc of EFFECTOR Therapeutics at 6.695 subject to Rule 16b-3 | ||
Byrnes Michael over six months ago Acquisition by Byrnes Michael of 4524 shares of EFFECTOR Therapeutics at 0.4973 subject to Rule 16b-3 | ||
Ehrlich Christopher B over six months ago Acquisition by Ehrlich Christopher B of 18867 shares of EFFECTOR Therapeutics at 0.55 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Disposition of 33799 shares by Stephen Worland of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Acquisition by Stephen Worland of 33799 shares of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 |
EFFECTOR Therapeutics Predictive Daily Indicators
EFFECTOR Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EFFECTOR Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding EFFECTOR Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in EFFECTOR Pink Sheet
If you are still planning to invest in EFFECTOR Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EFFECTOR Therapeutics' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |